US20050272120A1 - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor Download PDF

Info

Publication number
US20050272120A1
US20050272120A1 US11/102,501 US10250105A US2005272120A1 US 20050272120 A1 US20050272120 A1 US 20050272120A1 US 10250105 A US10250105 A US 10250105A US 2005272120 A1 US2005272120 A1 US 2005272120A1
Authority
US
United States
Prior art keywords
antibody
tat
polypeptide
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/102,501
Inventor
Patrick Dowd
Gretchen Frantz
Paul Polakis
Victoria Smith
Susan Spencer
Thomas Wu
Zemin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29950001P priority Critical
Priority to US17748802A priority
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to US11/102,501 priority patent/US20050272120A1/en
Assigned to GENENTECH, INC. reassignment GENENTECH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FRANTZ, GRETCHEN, POLAKIS, PAUL, SMITH, VICTORIA, SPENCER, SUSAN D., WU, THOMAS D., ZHANG, ZEMIN, DOWD, PATRICK
Publication of US20050272120A1 publication Critical patent/US20050272120A1/en
Priority claimed from KR1020077025841A external-priority patent/KR20080003405A/en
Priority claimed from US12/511,539 external-priority patent/US20090297531A1/en
Application status is Abandoned legal-status Critical

Links